RecallDepth
Class II Terminated

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01 Yellow, round, flat-faced, beveled-edge, unscored tablet. Debossed with 13 on one side and plain on the other side.

This recall has been terminated (originally issued October 10, 2018).

Company
Teva Pharmaceuticals Usa
Recall Initiated
September 21, 2018
Posted
October 10, 2018
Recall Number
D-0001-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
313 bottles
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

Distribution

Distributed nationwide in the USA

Lot / Code Info

Lot #: 34034024B, Exp 02/20

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls